Hepatotoxicity Induced by Azole Antifungal Agents: A Review Study
Iranian Journal of Pharmaceutical Research · 09.04.2023 · 22 (1)
DOI: 10.5812/ijpr-130336 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Iranian Journal of Pharmaceutical Research, online erschienen am 09.04.2023. Verfasst von Amin Rakhshan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Context:: Fungal infections are very common, and several medications are used to treat them. Azoles are prescribed widely to treat fungal infections. In addition to therapeutic effects, any drug can be accompanied by side effects in patients. One of the most important complications in this regard is liver injury. Therefore, hepatotoxicity induced by azole antifungal drugs were reviewed in this study. Evidence Acquisition:: English scientific papers were evaluated to review the effects of hepatotoxicity by azole antifungal agents, and the related studies' results were summarized using a table. The systematic search was implemented on electronic databases, including PubMed, Google Scholar, and Science Direct. Original articles and review articles that were published before April 1, 2022, were included in the study. Those articles without available full text or non-English articles were excluded. Also, articles that reported pediatric data were excluded. Results:: Most studies have reported the effects of hepatotoxicity by azole antifungal agents, and their mechanisms have been described. Conclusions:: Clinical evaluations regarding the hepatotoxicity of antifungal agents provided in the literature were reviewed. Therefore, it is recommended to prescribe these drugs with caution in high-risk patients suffering from liver diseases, and patients should be monitored for hepatotoxicity. However, more research is needed to evaluate the hepatotoxicity of azole antifungal agents and select appropriate drugs according to cost-effectiveness and the side effects' profiles, relying on lower incidence of this liver complication.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
- Pharmaceutical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Ali Saffaei, Maria Tavakoli-Ardakani
Zitieren
APA
Rakhshan, A., Rahmati Kamel, B., Saffaei, A., & Tavakoli-Ardakani, M. (2023). Hepatotoxicity Induced by Azole Antifungal Agents: A Review Study. Iranian Journal of Pharmaceutical Research, 22(1). https://doi.org/10.5812/ijpr-130336
Vancouver
Rakhshan A, Rahmati Kamel B, Saffaei A, Tavakoli-Ardakani M. Hepatotoxicity Induced by Azole Antifungal Agents: A Review Study. Iranian Journal of Pharmaceutical Research. 2023;22(1). doi:10.5812/ijpr-130336
BibTeX
@article{Rakhshan2023,
author = {Rakhshan, Amin and Rahmati Kamel, Bardia and Saffaei, Ali and Tavakoli-Ardakani, Maria},
title = {Hepatotoxicity Induced by Azole Antifungal Agents: A Review Study},
journal = {Iranian Journal of Pharmaceutical Research},
year = {2023},
volume = {22},
number = {1},
doi = {10.5812/ijpr-130336}
}
EUVIMED